Home
Resources and support

Resources and support

Educational resources and expert opinions

Hear from experts about their opinions on the primary care management of hypercholesterolaemia/mixed dyslipidaemia.

CLEAR Outcomes: Cardiovascular outcomes for bempedoic acid

Discover more about the CLEAR Outcomes trial results: Cardiovascular outcomes for bempedoic acid

Prof Derek Connolly, Prof Kausik Ray & Prof Terry McCormack

18 mins

Watch

Targeting Cholesterol: What do the guidelines recommend?

A focus on the recommendations around lipid modification therapy for the primary and secondary prevention of cardiovascular disease

8 mins

Watch

Lipid management: The importance of treating to target

Explore why lipid management is important for reducing the risk of cardiovascular disease

5 mins

Watch

Practical resources and information

These patient resources are only to be shared by HCPs to patients for whom the decision to prescribe NILEMDO®/NUSTENDI® has already been made. Please do not share this website directly with patients.

NUSTENDI® Patient Brochure

Downloadable brochure to support patients with their NUSTENDI® treatment

9 mins

Download

NILEMDO® Patient Brochure

Downloadable brochure to support patients with their NILEMDO® treatment

7.30 mins

Download

Access to implementation support and tools

This content is only for use by healthcare professionals in the UK and other appropriate decision-making personnel* that support the management of patient care.

This content should not replace individual clinical judgement or processes that may already be in place. Clinical judgement should be applied when considering the applicability of this content.

*Other relevant decision makers particularly include those with an NHS role who could influence in any way the administration, consumption, prescription, purchase, recommendation, sale, supply, or use of any medicine but who are not healthcare professionals.

The logistics of implementing guidance and treatment pathways can be challenging. Daiichi Sankyo UK is pleased to offer personalised support, to help you ensure that eligible patients have access to NILEMDO® or NUSTENDI® when they need it.

Support available:

Formularies and Treatment Pathway Support

Contact the DSUK SBD Regional Access Managers for promotional support in shaping the healthcare ecosystem to enable access to lipid-lowering therapies. This support may include guidance on formulary inclusion, optimising treatment pathways, and sharing best practice examples

Request

Education for Pharmacy Professionals

Contact the DSUK SBD Regional Access Managers to arrange promotional educational support for pharmacy professionals in your locality about the clinical and practical implementation of lipid management with NILEMDO® and/or NUSTENDI®

Request

Tools and materials available:

Lipid Implementation Pack

This toolkit offers valuable knowledge and practical strategies for the effective implementation of lipid management. This promotional resource is designed to support healthcare professionals in incorporating lipid-lowering therapies, such as NILEMDO® and NUSTENDI® into clinical practice. Funded and developed by DSUK

Request

Total System Value Pack

This model quantifies the burden of hypercholesterolaemia and mixed dyslipidaemia while demonstrating the holistic benefits of improved lipid management and goal attainment. This promotional offering is funded and developed by DSUK

Request

Further information

For information on Lipid Management Services offered by Daiichi Sankyo UK please see https://www.daiichi-sankyo.co.uk/about-us/responsibility/donations/ where you can submit a request for support or further information.

Adverse events should be reported

Reporting forms and information can be found at yellowcard.mhra.gov.uk (or search for MHRA Yellow Card in Google Play or Apple App store). Adverse events should also be reported to Daiichi Sankyo UK on 0800 028 5122 or by email to pharmacovigilance@daiichi-sankyo.co.uk

Safety profile Previous

Abbreviations

DSUK, Daiichi Sankyo UK; HCP, healthcare professional; SBD, specialty business division; UK, United Kingdom.

Job code: UK/BIL/11/24/0011|Date of preparation: February 2025

You are now leaving this website

Please note that our terms of use (especially those mentioned under "Terms and Conditions") are no longer valid as soon as you click on the "Continue" button. As we do not have any influence on linked websites, we assume no liability for their content or use. If you would like to return to our website, please click the "Return" button.

This is a Daiichi Sankyo site intended for UK healthcare professionals (HCPs) and other relevant decision makers,* where you can find promotional information about Daiichi Sankyo products and professional resources.

So that we can provide you with the most appropriate information, please choose one of the following options:

I am a UK healthcare professional

This website contains promotional information intended for UK healthcare professionals and other relevant decision makers only.

Confirm

I am a member of the public

This website provides members of the UK public with details about Daiichi Sankyo and its medicines. For further information about your health or medicines please consult your doctor, nurse or pharmacist.

Confirm

*Other relevant decision makers particularly includes those with an NHS role who could influence in any way the administration, consumption, prescription, purchase, recommendation, sale, supply, or use of any medicine but who are not healthcare professionals.